Medical research

Study targets key molecule to reverse kidney damage in mice

In findings that may lead to clinical trials of a promising new drug for kidney disease, researchers at Beth Israel Deaconess Medical Center (BIDMC) and their colleagues have identified a key molecular player and shown how ...

page 20 from 28